VNDA
Vanda Pharmaceuticals Inc
5.10$
+1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.3% | -8.2% | 15.9% | -13.7% | -30.6% | -3.4% | -66.2% | -29.0% | -56.2% | -51.4% | -97.1% | -160.9% | -89.3% | |
| 1.5% | 2.6% | 4.7% | 3.9% | 4.1% | 3.7% | 4.0% | -5.3% | 3.6% | 10.2% | 6.8% | 14.3% | 8.7% | |
| 8.2% | 7.2% | 7.6% | 5.9% | 6.3% | 5.4% | 5.9% | 4.0% | 3.8% | 4.0% | 5.0% | 9.2% | 5.4% | |
| -17.5% | 6.2% | 14.7% | -9.1% | -20.2% | 1.4% | -3.8% | 29.1% | -14.4% | 5.3% | -15.2% | 34.2% | 2.0% | |
| 0.1% | 0.6% | 0.0% | 0.2% | 0.3% | 0.4% | 0.9% | 0.6% | 0.3% | 0.2% | 0.4% | 0.8% | 0.4% | |
| 91.0% | -96.7% | -38.4% | -30.2% | 25.3% | 7.5% | 87.7% | -29.0% | 38.0% | 78.4% | 39.1% | 107.0% | 65.1% | |
| – | – | – | – | – | – | -0.8% | -0.8% | -0.9% | -1.1% | -1.5% | -1.7% | -1.3% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | -0.3% | -2.6% | -0.8% | -0.9% | -1.1% | -1.5% | -3.2% | -1.7% | |
| 85.4% | -104.6% | -22.5% | -44.0% | -5.2% | 3.4% | 18.9% | -58.6% | -19.5% | 26.1% | -59.8% | -57.3% | -25.9% | |
| -5.3% | -8.8% | 15.9% | -13.9% | -30.9% | -3.8% | -67.1% | -29.6% | -56.5% | -51.6% | -97.5% | -161.7% | -89.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.